Myt-healer, a wound healing short peptide
Effect of Myt-healer on the HaCat monolayer on an induced injury Dictated by continuously exposure to biological, chemical and physical aggressions, mussels have acquired a battery of defense weapons, such as Myt-C of Mytilus galloprovincialis.
Myt-C is a cysteine-rich peptide with known in vitro antibacterial, antiviral and chemotactic activities which is heavily produced upon tissue injury.
In vitro wound-healing assays and in vivo zebra fish regeneration studies showed a unique Myt-C biocompatible healing activity.
Myt-C healing function has been mapped in a short and easy to synthesized peptide sequence (Myt-healer).
Main innovations and advantages
· Myt-healer is a short peptide, easy to synthesize · Myt-healer can be used both in aqueous solutions or as a part of areleasing device.
· Myt-healer activity is retained in the presence of serum components.
· Myt-healer shows a strong wound healing: 5 μM Myt-healer seals theinduced injury in HaCaT (Culture Human Keratinocyte) monolayer in24 h.